Skip to main content
OpenTrials
Completed

NCT Number: NCT04241510

Effects of Kinesio Taping Techniques in COPD Patients

Study will investigate effects of two different kinesio taping techniques on pulmonary parameters of patients with COPD.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Muğla Sıtkı Koçman University Training and Research Hospital

Muğla, Menteşe, 48000, Turkey (Türkiye)

About this study

Chronic Obstructive Pulmonary Disease (COPD) is an irreversible, progressive, treatable airway disease which causes dyspnea, wheezing, coughing and increased secretions in airways. Thoracic and respiratory mechanics are impaired, respiratory muscle strength and functional exercise capacity is decreased in patients with COPD. As a result dyspnea, limitation in activities of daily living, postural impairments, muscle length-strength relationship changes and increased mechanical loads on respiratory muscles occur. In literature it has been demonstrated that Kinesio Taping have therapeutic effects on respiratory functions and functional exercise capacity in patients with chronic neurological diseases who has additional respiratory impairments. Although there are several studies in literature investigating the effects of facilitation and inhibition taping techniques applied on respiratory muscles in patients with COPD, effects of thoracic and postural mechanical correction techniques as an alternative treatment modality in patients with COPD have not been investigated yet. In present study, effects of thoracic mechanical correction and facilitation taping techniques in patients with COPD will be investigated, and data will be collected for effects of thoracic mechanical correction taping on pulmonary parameters in patients with COPD.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female COPD patients aged between 40-80 years
  • Diagnosed with COPD stage I-II-III-IV according to GOLD 2019 criterias
  • Able to speak, understand and read Turkish language
  • Volunteering to participate in study

Exclusion criteria

  • Unstable or acutely exacerbated patients with COPD
  • Alterations in medical treatment in last 6 months
  • Having comorbidities that affect directly cardiopulmonary system, uncontrolled arterial hypertension, severe congestive heart failure, coronary arterial disease, heart valve disease
  • Orthopaedic, neurological, psychiatric disease, peripheral/central nervous system diseases, mental retardation, antidepressants usage, metabolic impairments, malignancy
  • Unable to cooperate for measurement and treatment techniques used in study
  • Irritation, infection, allergic reaction, scarred burn or open wound around application area
  • Enrolled in a comprehensive pulmonary rehabilitation program before study
  • Application of Kinesio Tape to any body region in the past
  • History of an open heart surgery or other thoracic surgeries

Treatment and study plan

Kinesio taping

Device

Kinesio Taping is a special taping method developed by Dr. Kenzo Kase in 1973. This technique triggers natural healing responses of human body by activating nervous and circulatory systems. The tapes are thin, latex-free, cotton, porous and anti-allergenic, with equal thickness of epidermis. It has elastic properites which allows the tape to elongate to %55-60 of its original lenght. Tape can be used up to 1 week even after sweating or cleaning with water. There are different application techniques for different purposes. Facilitation technique facilitates muscle contractions and supports muscle function. Mechancial correction technique is used for joint positioning and correcting motion of muscle-joint dynamics.

Primary outcomes

  1. Pulmonary Function Test

    Time frame: 30 minutes after every application

    Pulmonary functions will be evaulated in laboratory conditions. Dynamic lung volumes will be measured using standardized spirometric measurement regulations established by ATS/ERS guidelines.

  2. Respiratory Muscle Strength

    Time frame: 30 minutes after every application

    Respiratory muscle strenght will be measured as Maximum Inspiratory Pressure & Maximum Expiratory Pressure with MicroMPM device. Measuring procedure will be held according to ERS guidelines. Measurements will be interpreted with Black and Hyatt's references.

  3. Functional Exercise Capacity

    Time frame: 30 minutes after every application

    Functional exercise capacity will be measured with 6-minute walk test. Cardiovascular paremeters, dyspnea, respiratory rate and fatigue will be evaulated before, during and after the test .

  4. Dyspnea

    Time frame: 30 minutes after each application

    Dyspnea in daily living was evaluated by the Modified Medical Research Council Dyspnea Scale. The scale consists in five statements that describe almost the entire range of dyspnea from none (Grade 0) to almost complete incapacity (Grade 4). Higher scores indicates increased dyspnea perception.

Secondary outcomes

  1. Perception of Disease

    Time frame: 30 minutes after each application.

    COPD Assesment Test (CAT) will be used to evaulate patients perception of symptoms.

Sponsors and collaborators

Lead sponsor

Muğla Sıtkı Koçman University

Other

Registry information

Official study title

Effects of Kinesio Taping Techniques on Pulmonary Parameters and Functional Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jan 27, 2020
Registry last updated
Nov 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.